País: Nova Zelanda
Idioma: anglès
Font: Medsafe (Medicines Safety Authority)
Tenoxicam 22mg
AFT Pharmaceuticals Ltd
Tenoxicam 22 mg
20 mg
Powder for injection
Active: Tenoxicam 22mg Excipient: Ascorbic acid Disodium edetate Hydrochloric acid Mannitol Sodium hydroxide as 10% solution Trometamol Water for injection
Vial, glass, single dose, 3 mL colourless type 1 glass vial with bromobutyl rubber stopper and aluminium cap., 1 dose unit
Prescription
Prescription
Edmond Pharma SRL
Tenoxicam Lyophilisate is indicated for: · The relief of pain and inflammation in osteoarthritis and rheumatoid arthritis.
Package - Contents - Shelf Life: Vial, glass, single dose, 3 mL colourless type 1 glass vial with bromobutyl rubber stopper and aluminium cap. - 1 dose units - 3 years from date of manufacture stored at or below 30°C 24 hours reconstituted stored at or below 30°C
2009-11-16
TENOXICAM TENOXICAM, 20 MG, POWDER FOR INJECTION QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 20 mg tenoxicam as lyophilised sterile powder for reconstitution. Tenoxicam is 4-hydroxy-2-methyl-N-2-pyridyl-2H-thieno-[2, 3e]-1,2-thiazine-3-carboxamide- 1, 1-dioxide, a non-steroidal anti-inflammatory agent. For full list of excipients, see section _List of excipients_. PHARMACEUTICAL FORM Vials for I.V. or I.M. administration. CLINICAL PARTICULARS _THERAPEUTIC INDICATIONS _ Tenoxicam Lyophilisate is indicated for: • the relief of pain and inflammation in osteoarthritis and rheumatoid arthritis, • the short term management of acute musculoskeletal disorders including strains, sprains and other soft-tissue injuries, and • the management of postoperative pain. I.V., I.M. tenoxicam can be used for these indications in those patients considered unable to take oral tenoxicam. _POSOLOGY AND METHOD OF ADMINISTRATION _ Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section _Special warnings and precautions for _ _use_). ADULTS Tenoxicam Lyophilisate should be given I.V. or I.M. A single daily dose of 20 mg for one to two days initially, to be continued with the oral form, with administration at the same time each day. The lyophilisate should be dissolved in 2 mL of sterile water for injections and the reconstituted solution should be used immediately. Higher doses should be avoided as they do not usually achieve significantly greater therapeutic effect but may be associated with a higher risk of adverse events. In Llegiu el document complet